Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sanaria and the University of Maryland Biotechnology Institute have received a multi-year small business innovation research grant from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health.
Subscribe to our email newsletter
The small business innovation research (SBIR) grant will support research and development efforts to genetically engineer mosquitoes that can enhance Sanaria’s whole-parasite malaria vaccine production process.
David O’Brochta, director of the Insect Transformation Facility at University of Maryland Biotechnology (UMBI), said: “The partnership between Sanaria and UMBI supported by this SBIR grant is an ideal example of public-private partnership in the development of groundbreaking technology.
“It presents an extraordinary opportunity to exploit the capabilities of our Insect Transformation Facility in pursuit of a goal of enormous biomedical importance.”